Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-23-000004

EVP Finance CFO sold 1,190 shares at an average $823.20 ($979,605)

  • EVP Finance CFO gave up 2,793 shares (to pay taxes)
  • EVP Finance CFO acquired 3,800 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Landry Robert E · EVP Finance CFO

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-27 Exercise or conversion : show line 1 in the form 10b5-1 +800 $381.92 $305,536 32,905 D
2023-03-27 Shares withheld for taxes : show line 2 in the form 10b5-1 −589 $825.17 $486,025 32,316 D
2023-03-27 Exercise or conversion : show line 3 in the form 10b5-1 +3,000 $378.98 $1,136,940 35,316 D
2023-03-27 Shares withheld for taxes : show line 4 in the form 10b5-1 −2,204 $825.17 $1,818,675 33,112 D
2023-03-27 Sale : show line 5 in the form 10b5-1 −39 $819.47 $31,959 33,073 D
2023-03-27 Sale : show line 6 in the form 10b5-1 −50 $820.46 $41,023 33,023 D
2023-03-27 Sale : show line 7 in the form 10b5-1 −48 $821.39 $39,427 32,975 D
2023-03-27 Sale : show line 8 in the form 10b5-1 −18 $822.57 $14,806 32,957 D
Open-market sales · 1,190 sh · avg $823.20 · $979,605

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-27 Exercise or conversion : show line 21 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −3,000 20,337 D
2023-03-27 Exercise or conversion : show line 22 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −800 0 D
Loading xslF345X04/edgardoc.xml…